Loading...

358 posters, 97 topics, 122 sessions, 958 authors, 239 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

79th PostGraduate Assembly in Anesthesiology 2025

December 12 - 15, 2025 | New York City

79th PostGraduate Assembly in Anesthesiology 2025 banner

2123

Anesthetic considerations in Nonbacterial Thrombotic Endocarditis: Intraoperative Heparin Resistance and Hypercoagulability in Cardiac Surgery

Part of Topic

Cardiovascular - Perioperative Management

Introduction

Nonbacterial thrombotic endocarditis (NBTE) is a rare condition typically associated with malignancy or autoimmune disorders. It presents unique diagnostic and perioperative challenges. The case presents the anesthetic management of a 37-year-old female with NBTE requiring surgical excision of mitral valve vegetation.

 


 

Case Summary

  • The patient is a 37F with a complex hypercoagulable history, including multiple spontaneous abortions, recurrent VTE (including PEs on anticoagulation), and uterine fibroids.

  • She was referred for mitral valve surgery due to enlarging vegetations on TEE (1 cm anterior leaflet, 2 mm posterior kissing lesion).

  • Extensive infectious and autoimmune workup was negative.

  • Diagnosis: Nonbacterial thrombotic endocarditis (NBTE).

  • The plan was for vegetation excision with possible valve replacement.

 


 

Preoperative Planning

  • Multidisciplinary collaboration was conducted with cardiology, infectious disease, cardiothoracic surgery, and hematology.

  • Heparin resistance was anticipated based on clinical history.

  • A pre-induction arterial line was placed.

  • Induction was performed with IV midazolam, fentanyl, lidocaine, propofol, and rocuronium.

  • Post-induction, a central line and PA catheter were placed.

 


 

Intraoperative Course

  • An initial heparin bolus of $300~u/kg$ did not achieve an ACT >400.

  • A repeat bolus was ineffective; the ACT remained <400.

  • The Pre-op AT III level was 74% (normal: 80-120%).

  • Intraoperative AT III administration was given to achieve an ACT >400, and CPB was initiated.

  • Successful mitral valve vegetation excision was performed, and the valve was preserved.

 


 

Postoperative Management

  • Heparin infusion was bridged to warfarin (goal INR 2.5).

  • Daptomycin was initiated due to MRSE growth from intraoperative cultures.

  • Weekly monitoring labs included CBC, CMP, ESR, CRP, and CPK.

  • Pain control utilized non-narcotic analgesia and lidoderm.

  • Post Op pericarditis was managed with colchicine and ibuprofen.

 


 

Discussion

  • NBTE vs. Infective Endocarditis (IE) Differences:

    • NBTE vegetations are typically small, noninvasive, and non-destructive

    • Unlike infective endocarditis, NBTE vegetations rarely cause overt hemodynamic compromise

    • Despite being non-destructive, NBTE vegetations still pose a substantial risk of systemic embolization

  • Anticoagulation Challenges (Heparin Resistance):

    • NBTE presents unique anesthetic challenges driven by its prothrombotic state and embolic potential

    • In this case, heparin resistance was recognized only after the failure of two 300 u/kg boluses to achieve the target ACT

    • Borderline AT III levels likely contributed to this resistance

    • Functional AT III deficiency is a known but often underrecognized contributor to heparin resistance, especially in hypercoagulable states

  • Management and Anesthesiologist's Role:

    • The necessity for swift intraoperative troubleshooting is underscored by the failed heparin boluses

    • Timely administration of AT III concentrate was essential, as it restored adequate anticoagulation, allowing for safe progression to cardiopulmonary bypass (CPB)

    • Anesthesiologists must anticipate unpredictable ACT kinetics in NBTE

    • It's necessary to ensure immediate access to adjunctive anticoagulants (e.g., AT III, Fresh Frozen Plasma (FFP), Direct thrombin inhibitors)

    • Multidisciplinary coordination is vital for surgical and anesthetic planning.

pga2025 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.